InsidersTradesSigma
Follow the SYN2BIO S.A. stock price and the full insider trade history of the company, a publicly traded company based in Poland. Shares are listed on PL PL, under the authority of KNF. Operating in the Health Care sector, SYN2BIO S.A. has recorded 4 reports. Market capitalisation: €295m. The latest transaction was reported on 18 May 2026 (Notification PDMR). Among the most active insiders: Anonymous (PDMR). All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.